ARC ANTI-HBS RGT 100T A

  • €102.49
    Unit price per 
Tax included.


H1: ARC ANTI-HBS RGT 100T A - Reliable Hepatitis B Screening Solution
The ARC ANTI-HBS RGT 100T A is a cutting-edge diagnostic tool designed for the accurate detection of Hepatitis B surface antibodies in human serum or plasma. It provides healthcare professionals with a reliable means to assess immunity against Hepatitis B, enhancing patient care and facilitating appropriate medical responses. This test kit is essential in clinical settings where precise and rapid diagnostics are critical for effective patient management.

Key Features & Benefits:
- Rapid Results: Experience swift and accurate test results that help you make informed medical decisions without delay, ensuring timely patient care.
- High Sensitivity: With a high sensitivity rate, this test minimizes the risks of false negatives, providing confidence in the immunity assessment and reducing the need for retesting.
- User-Friendly Protocol: Designed for straightforward use, the ARC ANTI-HBS RGT 100T A features a simple testing procedure that can be easily integrated into any laboratory workflow.
- Stable Shelf Life: This product boasts a long shelf life, offering convenience and reliability while maintaining quality performance, even when stored for extended periods.
- Comprehensive Manual: Included is a detailed user manual that provides guidance on best practices for testing, interpretation of results, and troubleshooting, ensuring optimal usability for medical professionals.

Technical Specifications:
- Model Number: ARC ANTI-HBS RGT 100T A
- Test Type: Enzyme-Linked Immunosorbent Assay (ELISA)
- Sample Type: Human serum or plasma
- Assay Duration: Approximately 1-2 hours
- Storage Temperature: 2°C to 8°C
- Shelf Life: 24 months from manufacturing date

The ARC ANTI-HBS RGT 100T A is an indispensable tool for any clinical laboratory focused on accurate Hepatitis B immunity screening. Equip your practice with this essential diagnostic solution for confident patient care and effective disease management.